DART Therapeutics Inc., Cambridge, Mass., is a biotechnology firm applying a new model for drug development to rare pediatric neuromuscular diseases. In the DART model, patient foundations join with biotechnology industry veterans to impact a central problem in rare diseases: Rapid therapy development. DART is focused on DMD, a fatal neuromuscular disease for which there is no effective treatment. ( http://www.dartrx.com).Contacts: Biovista, Inc. Aris Persidis +1-434-242-6514 firstname.lastname@example.org DART Therapeutics, Inc. Shanti Skiffington +1-617-921-0808 email@example.com
Biovista And DART Therapeutics Enter Into Drug Repositioning Collaboration Targeting Duchenne Muscular Dystrophy
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.